Dipharma Francis Srl, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CHENODEOXYCHOLIC ACID, with a corresponding US DMF Number 34160.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 10, 2020, and payment made on October 29, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II